Edema

·MeSH: Edema

65 drugs in development·42 companies·2 clinical trials

Drug Pipeline by Phase

Approved(20)

Drug	Company
acetazolamide	Mylan II B.V. (MYL)
acetazolamide	MANNKIND CORP (MNKD)
acetazolamide	Greenwich LifeSciences, Inc. (GLSI)
acetazolamide	ACHIEVE LIFE SCIENCES, INC. (ACHV)
acetazolamide	Prestige Consumer Healthcare Inc. (PBH)
Bumetanide for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
DAWNZERA™ (donidalorsen)	IONIS PHARMACEUTICALS INC (IONS)
ekterly	KalVista Pharmaceuticals, Inc. (KALV)
fosinopril	Teva Pharmaceutical Industries Limited (TEVA)
ILUVIEN	ANI PHARMACEUTICALS INC (ANIP)
levothyroxine	MAIA Biotechnology, Inc. (MAIA)
orladeyo	BIOCRYST PHARMACEUTICALS INC (BCRX)
Orladeyo	Royalty Pharma plc (RPRX)
ORLADEYO (berotralstat)	BIOCRYST PHARMACEUTICALS INC (BCRX)
ozurdex	AbbVie Inc. (ABBV)
sofpulse	ENDONOVO THERAPEUTICS, INC. (ENDV)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
vabysmo	XOMA Royalty Corporation (XOMA)
XIPERE	Clearside Biomedical, Inc. (CLSDQ)

Phase 3(16)

Drug	Company
4D-150	4D Molecular Therapeutics, Inc. (FDMT)
4D-150 IVT	4D Molecular Therapeutics, Inc. (FDMT)
ARVN001 (Arcatus)	Clearside Biomedical, Inc. (CLSDQ)
avt29	Alvotech (ALVO)
Berotralstat	BIOCRYST PHARMACEUTICALS INC (BCRX)
deucrictibant	Pharvaris N.V. (PHVS)
drug	KalVista Pharmaceuticals, Inc. (KALV)
eylea hd	Alvotech (ALVO)
ksi-101	Kodiak Sciences Inc. (KOD)
m710	MOMENTA PHARMACEUTICALS INC (MNTA)
navenibart	BIOCRYST PHARMACEUTICALS INC (BCRX)
navenibart	Astria Therapeutics, Inc. (ATXS)
NTLA-2002	Intellia Therapeutics, Inc. (NTLA)
opt-302	Opthea Ltd (OPTEY)
ORLADEYO (berotralstat) oral granule formulation	BIOCRYST PHARMACEUTICALS INC (BCRX)
otl-105	Orchard Therapeutics plc (ORTX)

Phase 2(10)

Drug	Company
Antiretroviral Therapy	Valneva SE (VALN)
ar-1105	AERIE PHARMACEUTICALS INC (AERI)
donidalorsen	IONIS PHARMACEUTICALS INC (IONS)
experimental	Rezolute, Inc. (RZLT)
foselutoclax	Unity Biotechnology, Inc. (UBX)
kio-104	Kiora Pharmaceuticals Inc. (KPRX)
kvd824	KalVista Pharmaceuticals, Inc. (KALV)
rz402	Rezolute, Inc. (RZLT)
STAR-0215	Astria Therapeutics, Inc. (ATXS)
tonabersat	GH Research PLC (GHRS)

Phase 1(4)

Drug	Company
Advair HFA	UNITED THERAPEUTICS Corp (UTHR)
ARVN011	Clearside Biomedical, Inc. (CLSDQ)
Avoralstat	BIOCRYST PHARMACEUTICALS INC (BCRX)
ocu200	Ocugen, Inc. (OCGN)

Preclinical(3)

Drug	Company
acu-6151	KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (ACUC)
szn-8141	Surrozen Inc. (SRZN)
szn-8143	Surrozen Inc. (SRZN)

Unknown(4)

Drug	Company
icatibant	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
icatibant	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
lanadelumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
lanadelumab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 1/Phase 2(1)

Drug	Company
biological ntla-2002	Intellia Therapeutics, Inc. (NTLA)

Phase 4(7)

Drug	Company
brolucizumab	NOVARTIS AG (NVSEF)
brolucizumab	Novartis AG (NVS)
chloroprocaine ophthalmic gel 3%	HARROW, INC. (IMMY)
fluorometholone acetate ophthalmic suspension 0.1%	HARROW, INC. (IMMY)
kvd900	KalVista Pharmaceuticals, Inc. (KALV)
proparacaine hydrochloride ophthalmic solution 0.5%	HARROW, INC. (IMMY)
sebetralstat odt	KalVista Pharmaceuticals, Inc. (KALV)

BioSniper tracks 65 drugs in development for Edema across 42 companies.

There are 2 clinical trials targeting Edema tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.